RIVICICLIB

SynDRA canonical compound SYN0038262 — structure-anchored drug synonym record

Clinical phase	Phase 2
Primary target(s)	CDK1 \| CDK4 \| CDK9
Mechanism of action	CDK inhibitor

All known targets

CDK1
CDK4
CDK9

Mechanisms of action (all sources)

CDK1 INHIBITOR
CDK4/6 inhibitor
CDK9 INHIBITOR
cyclin-dependent kinase inhibitor
CDK4 INHIBITOR

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CCNA1
CCNA2
SYK
NTMT1
NTM1A
NSD2
KSYK
IFNB1
HLAB
CDK6
CDK2
CCNT1
CCND3
CCND1
CCNB3
CCNB2
CCNB1
TP53

Cross-references

PubChem CID: 23643975
ChEMBL: CHEMBL3545283
TTD: D05IRT

Synonyms

P-276-00 free base
P276-00
CHEMBL2312181
SCHEMBL1180418
SCHEMBL665748
SCHEMBL31702788
HMS3674I05
BDBM50404388
NCGC00389231-01
NCGC00389231-02
DB-073528

Look up RIVICICLIB in the interactive SynDRA portal →